CY1110366T1 - Ασεναπινη για τη θεραπεια της σχιζοφρενειας σε ενα υπερβαρο ασθενη ή που εχει προδιαθεση να γινει υπερβαρος - Google Patents
Ασεναπινη για τη θεραπεια της σχιζοφρενειας σε ενα υπερβαρο ασθενη ή που εχει προδιαθεση να γινει υπερβαροςInfo
- Publication number
- CY1110366T1 CY1110366T1 CY20081100659T CY081100659T CY1110366T1 CY 1110366 T1 CY1110366 T1 CY 1110366T1 CY 20081100659 T CY20081100659 T CY 20081100659T CY 081100659 T CY081100659 T CY 081100659T CY 1110366 T1 CY1110366 T1 CY 1110366T1
- Authority
- CY
- Cyprus
- Prior art keywords
- asenapine
- patient
- treatment
- schizophrenia
- supervisor
- Prior art date
Links
- VSWBSWWIRNCQIJ-GJZGRUSLSA-N (R,R)-asenapine Chemical compound O1C2=CC=CC=C2[C@@H]2CN(C)C[C@H]2C2=CC(Cl)=CC=C21 VSWBSWWIRNCQIJ-GJZGRUSLSA-N 0.000 title abstract 2
- 229960005245 asenapine Drugs 0.000 title abstract 2
- 201000000980 schizophrenia Diseases 0.000 title abstract 2
- 230000000561 anti-psychotic effect Effects 0.000 abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 1
- 206010033307 Overweight Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 230000004584 weight gain Effects 0.000 abstract 1
- 235000019786 weight gain Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03101721 | 2003-06-12 | ||
| EP04766041A EP1635820B1 (en) | 2003-06-12 | 2004-06-09 | Asenapine for the treatment of schizophrenia in a patient with overweight or predisposition for overweight |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1110366T1 true CY1110366T1 (el) | 2014-04-09 |
Family
ID=33547705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20081100659T CY1110366T1 (el) | 2003-06-12 | 2008-06-24 | Ασεναπινη για τη θεραπεια της σχιζοφρενειας σε ενα υπερβαρο ασθενη ή που εχει προδιαθεση να γινει υπερβαρος |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20060128688A1 (zh-cn) |
| EP (1) | EP1635820B1 (zh-cn) |
| JP (1) | JP2006527238A (zh-cn) |
| KR (1) | KR20060020664A (zh-cn) |
| CN (1) | CN1816335A (zh-cn) |
| AR (1) | AR044675A1 (zh-cn) |
| AT (1) | ATE395914T1 (zh-cn) |
| AU (1) | AU2004246820B2 (zh-cn) |
| BR (1) | BRPI0411237A (zh-cn) |
| CA (1) | CA2528365A1 (zh-cn) |
| CY (1) | CY1110366T1 (zh-cn) |
| DE (1) | DE602004013966D1 (zh-cn) |
| DK (1) | DK1635820T3 (zh-cn) |
| ES (1) | ES2305829T3 (zh-cn) |
| IL (1) | IL172397A (zh-cn) |
| NO (1) | NO20055884L (zh-cn) |
| NZ (1) | NZ544018A (zh-cn) |
| PL (1) | PL1635820T3 (zh-cn) |
| PT (1) | PT1635820E (zh-cn) |
| RU (1) | RU2352336C2 (zh-cn) |
| SI (1) | SI1635820T1 (zh-cn) |
| TW (1) | TWI327915B (zh-cn) |
| WO (1) | WO2004110437A1 (zh-cn) |
| ZA (1) | ZA200509904B (zh-cn) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1710245T3 (da) * | 2005-04-07 | 2007-12-03 | Organon Nv | Krystalform af asenapinmaleat |
| US7741358B2 (en) | 2005-04-14 | 2010-06-22 | N.V. Organon | Crystal form of asenapine maleate |
| MX382195B (es) | 2016-12-20 | 2025-03-13 | Lts Lohmann Therapie Systeme Ag | Sistema terapeutico transdermico que contiene asenapina |
| US11337932B2 (en) | 2016-12-20 | 2022-05-24 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene |
| JP2020525545A (ja) | 2017-06-26 | 2020-08-27 | エルテーエス ローマン テラピー−ジステーメ アーゲー | アセナピンおよびシリコーンアクリルハイブリッドポリマーを含有する経皮治療システム |
| US11648213B2 (en) | 2018-06-20 | 2023-05-16 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine |
| EP3810099A1 (en) | 2018-06-20 | 2021-04-28 | LTS Lohmann Therapie-Systeme AG | Transdermal therapeutic system containing asenapine |
| WO2020106330A1 (en) * | 2018-07-18 | 2020-05-28 | Pillsy, Inc. | Smart drug delivery and monitoring device, kit, and method of use for pill compounds |
| IL291775A (en) * | 2019-12-11 | 2022-06-01 | Corcept Therapeutics Inc | Methods for the treatment of obesity caused by antipsychotic treatment using Miricurilent |
| RU2756614C1 (ru) * | 2021-04-07 | 2021-10-04 | Федеральное государственное бюджетное научное учреждение «Томский национальный исследовательский медицинский центр Российской академии наук» (Томский НИМЦ) | Способ поддержки принятия врачебных решений выбора антипсихотической терапии у больных шизофренией с целью профилактики акатизии |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL180465B1 (pl) * | 1994-03-02 | 2001-02-28 | Akzo Nobel Nv | Kompozycja farmaceutyczna zawierajaca trans-5-chloro-2-metylo-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oksepino[4,5-c]pirol PL PL PL |
| US5496831A (en) * | 1994-05-13 | 1996-03-05 | The General Hospital Corporation | Inhibition of insulin-induced adiposis |
| JP2004517112A (ja) * | 2001-01-02 | 2004-06-10 | ファルマシア・アンド・アップジョン・カンパニー | 新規薬物コンビネーション |
-
2004
- 2004-06-03 TW TW093116017A patent/TWI327915B/zh not_active IP Right Cessation
- 2004-06-09 CN CNA200480018591XA patent/CN1816335A/zh active Pending
- 2004-06-09 BR BRPI0411237-7A patent/BRPI0411237A/pt not_active IP Right Cessation
- 2004-06-09 JP JP2006516141A patent/JP2006527238A/ja active Pending
- 2004-06-09 DK DK04766041T patent/DK1635820T3/da active
- 2004-06-09 CA CA002528365A patent/CA2528365A1/en not_active Abandoned
- 2004-06-09 PT PT04766041T patent/PT1635820E/pt unknown
- 2004-06-09 AT AT04766041T patent/ATE395914T1/de active
- 2004-06-09 ES ES04766041T patent/ES2305829T3/es not_active Expired - Lifetime
- 2004-06-09 DE DE602004013966T patent/DE602004013966D1/de not_active Expired - Lifetime
- 2004-06-09 AU AU2004246820A patent/AU2004246820B2/en not_active Ceased
- 2004-06-09 SI SI200430755T patent/SI1635820T1/sl unknown
- 2004-06-09 KR KR1020057023646A patent/KR20060020664A/ko not_active Ceased
- 2004-06-09 WO PCT/EP2004/051069 patent/WO2004110437A1/en active IP Right Grant
- 2004-06-09 EP EP04766041A patent/EP1635820B1/en not_active Expired - Lifetime
- 2004-06-09 US US10/560,554 patent/US20060128688A1/en not_active Abandoned
- 2004-06-09 PL PL04766041T patent/PL1635820T3/pl unknown
- 2004-06-09 RU RU2006101061/14A patent/RU2352336C2/ru not_active IP Right Cessation
- 2004-06-09 NZ NZ544018A patent/NZ544018A/en not_active IP Right Cessation
- 2004-06-11 AR ARP040102026A patent/AR044675A1/es unknown
-
2005
- 2005-12-06 IL IL172397A patent/IL172397A/en not_active IP Right Cessation
- 2005-12-06 ZA ZA200509904A patent/ZA200509904B/en unknown
- 2005-12-12 NO NO20055884A patent/NO20055884L/no not_active Application Discontinuation
-
2008
- 2008-06-24 CY CY20081100659T patent/CY1110366T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1816335A (zh) | 2006-08-09 |
| PL1635820T3 (pl) | 2008-10-31 |
| KR20060020664A (ko) | 2006-03-06 |
| BRPI0411237A (pt) | 2006-07-11 |
| RU2006101061A (ru) | 2006-07-27 |
| PT1635820E (pt) | 2008-06-17 |
| RU2352336C2 (ru) | 2009-04-20 |
| JP2006527238A (ja) | 2006-11-30 |
| CA2528365A1 (en) | 2004-12-23 |
| WO2004110437A1 (en) | 2004-12-23 |
| NO20055884L (no) | 2006-01-03 |
| AU2004246820A1 (en) | 2004-12-23 |
| AR044675A1 (es) | 2005-09-21 |
| TW200501946A (en) | 2005-01-16 |
| IL172397A0 (en) | 2006-04-10 |
| HK1084894A1 (en) | 2006-08-11 |
| IL172397A (en) | 2010-06-16 |
| ES2305829T3 (es) | 2008-11-01 |
| EP1635820B1 (en) | 2008-05-21 |
| EP1635820A1 (en) | 2006-03-22 |
| TWI327915B (en) | 2010-08-01 |
| DE602004013966D1 (de) | 2008-07-03 |
| DK1635820T3 (da) | 2008-09-08 |
| ZA200509904B (en) | 2006-12-27 |
| SI1635820T1 (sl) | 2008-08-31 |
| US20060128688A1 (en) | 2006-06-15 |
| AU2004246820B2 (en) | 2009-10-01 |
| NZ544018A (en) | 2008-07-31 |
| ATE395914T1 (de) | 2008-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110366T1 (el) | Ασεναπινη για τη θεραπεια της σχιζοφρενειας σε ενα υπερβαρο ασθενη ή που εχει προδιαθεση να γινει υπερβαρος | |
| CY1107440T1 (el) | Ενωσεις αρυλουριας εν συνδυασμω με αλλα κυτταροστατικα ή κυτταροτοξικα μεσα για τη θεραπεια ανθρωπινων καρκινων | |
| CY1121134T1 (el) | Συνθεσεις και μεθοδοι για την τροποποιηση της smn2 συγκολλησης | |
| CY1106476T1 (el) | Υποκατεστημενες διυδροκιναζολινες με αντι-ιικες ιδιοτητες | |
| CY1118902T1 (el) | Ρυθμιση της δραστικοτητας των προνευροτροφινων | |
| CY1110889T1 (el) | C-αρυλο γλυκοζιτικοι sglt2 αναστολεις και μεθοδος για την παραγωγη τους | |
| CY1114277T1 (el) | ΕΝΩΣΕΙΣ ΙΜΙΔΑΖΟ[1,2-a]ΠΥΡΙΔΙΝΗΣ ΩΣ ΑΝΑΣΤΟΛΕΙΣ ΥΠΟΔΟΧΕΑ ΚΙΝΑΣΗΣ ΤΥΡΟΣΙΝΗΣ | |
| CY1114272T1 (el) | Υποκατεστημενες διυδροπυραζολονες για την θεραπευτικη αντιμετωπιση των καρδιαγγειακων και αιματολογικων παθησεων | |
| CY1111692T1 (el) | ΠΑΡΑΓΩΓΑ ΙΝΔΟΛΗΣ Ή ΒΕΝΖΙΜΙΔΑΖΟΛΗΣ ΓΙΑ ΤΗ ΡΥΘΜΙΣΗ ΤΗΣ ΙκΒ ΚΙΝΑΣΗΣ | |
| CY1108843T1 (el) | 3,11β cis διϋδροτετραβεναζινη για την θεραπεια της σχιζοφρενιας και αλλων ψυχωσεων | |
| CY1117217T1 (el) | Συνθεση και αντι-ιικη δραστηριοτητα των υποκατεστημενων παραγωγων αζαϊνδολοοξοοξικης πιπεραζινης | |
| CY1114089T1 (el) | Μακροχρονια θεραπεια της μολυνσης απο hiv με tcm278 | |
| DE50310516D1 (de) | Fredericamycin-derivate | |
| PA8637301A1 (es) | Derivados de amino-5, 5-difenilimidazolona para la inhibicion de la b-secretasa | |
| PA8637201A1 (es) | Difenilimidazopirimidina e-imidazol aminas como inhibidores de la b-secretasa | |
| CY1110665T1 (el) | Αναστολεις hiv ιντεγκρασης | |
| ATE442142T1 (de) | Fredericamycin-derivate als arzneimittel zur tumorbehandlung | |
| UY28923A1 (es) | Compuestos terapéuticos: piridina como estructura base | |
| CY1109660T1 (el) | Η χρηση της οξυκωδονης για την θεραπευτικη αντιμετωπιση του σπλαγχνικου πονου | |
| CY1110127T1 (el) | Υποκατεστημενες 1-προπιολυλο-πιπεραζινες με χημικη συγγενεια για τον υποδοχεα mglur5 για τη θεραπεια καταστασεων πονου | |
| CY1115227T1 (el) | Νεοι καταστολεις φωσφοδιεστερασης (phosphodiesterase) | |
| ECSP055964A (es) | Heterociclil-3-sulfonilindazoles como ligandos de 5-hidroxitriptamina-6 | |
| CY1117504T1 (el) | Παραγωγα 1-βενζυλ-3-υδροξυμεθυλινδαζολης και η χρηση τους στη θεραπευτικη αντιμετωπιση νοσων που βασιζονται στην εκφραση των mcp-1, και cx3cr1 | |
| TW200630374A (en) | Thiazolyldihydroindazoles | |
| CY1113059T1 (el) | Οργανικες ενωσεις |